{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:04:56Z","timestamp":1773248696301,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,4,9]],"date-time":"2011-04-09T00:00:00Z","timestamp":1302307200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1245\/s10434-011-1706-3","type":"journal-article","created":{"date-parts":[[2011,4,8]],"date-time":"2011-04-08T23:33:09Z","timestamp":1302305589000},"page":"2925-2936","source":"Crossref","is-referenced-by-count":50,"title":["Racial Differences in Survival after Surgical Treatment for Melanoma"],"prefix":"10.1245","volume":"18","author":[{"given":"Karen Kadela","family":"Collins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan C.","family":"Fields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dadrie","family":"Baptiste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Moley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna B.","family":"Jeffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,4,9]]},"reference":[{"key":"1706_CR1","unstructured":"National Institutes of Health (2010).SEER Cancer statistics review, 1975\u20132007. http:\/\/seer.cancer.gov\/csr\/1975_2007\/ (July 15, 2010)."},{"key":"1706_CR2","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/cncr.21654","volume":"106","author":"M Cockburn","year":"2006","unstructured":"Cockburn M, Zadnick J, Deapen D. Developing epidemic of melanoma in the Hispanic population of California. Cancer. 2006;106:1162\u20138.","journal-title":"Cancer."},{"key":"1706_CR3","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/archdermatol.2009.302","volume":"145","author":"S Hu","year":"2009","unstructured":"Hu S, Parmet Y, Allen G, et al. Disparity in melanoma: a trend analysis of melanoma incidence and stage at diagnosis among Whites, Hispanics and Blacks in Florida. Arch Dermatol. 2009;145:1369\u201374.","journal-title":"Arch Dermatol."},{"key":"1706_CR4","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1001\/archinte.166.17.1907","volume":"166","author":"JN Cormier","year":"2006","unstructured":"Cormier JN, Xing Y, Ding M, et al. Ethnic differences among patients with cutaneous melanoma. Arch Intern Med. 2006;166:1907\u201314.","journal-title":"Arch Intern Med."},{"key":"1706_CR5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.sder.2009.04.005","volume":"28","author":"BA Shoo","year":"2009","unstructured":"Shoo BA, Kashani-Sabet M. Melanoma arising in African-, Asian-, Latino- and Native-American populations. Semin Cutan Med Surg. 2009;28:96\u2013102.","journal-title":"Semin Cutan Med Surg."},{"key":"1706_CR6","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/archsurg.139.9.968","volume":"139","author":"DE Hemmings","year":"2004","unstructured":"Hemmings DE, Johnson DS, Tominaga GT, Wong JH. Cutaneous melanoma in a multiethnic population: is this a different disease? Arch Surg. 2004;139:968\u201373.","journal-title":"Arch Surg."},{"key":"1706_CR7","first-page":"203","volume":"67","author":"Z Rahman","year":"2001","unstructured":"Rahman Z, Taylor SC. Malignant melanoma in African Americans. Cutis. 2001 67:203\u2013406.","journal-title":"Cutis."},{"key":"1706_CR8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1200\/JCO.2007.12.3604","volume":"26","author":"JA Zell","year":"2008","unstructured":"Zell JA, Cinar P, Mobasher M, Ziogas A, Meyskens FL Jr, Anton-Culver H. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol. 2008;26:66\u201375.","journal-title":"J Clin Oncol."},{"key":"1706_CR9","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/cncr.21760","volume":"106","author":"S Verma","year":"2006","unstructured":"Verma S, Quirt I, McCready D, Bak K, Charette M, Iscoe N. Systmatic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma. Cancer. 2006;106:1431\u201342.","journal-title":"Cancer."},{"issue":"Suppl. 6","key":"1706_CR10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/annonc\/mdp250","volume":"20","author":"A Eggermont","year":"2009","unstructured":"Eggermont A, Teston A, Marsden J, et al. Utility of adjuvant systemic therapy in melanoma. Ann Oncol. 2009;20(Suppl. 6):30\u20134.","journal-title":"Ann Oncol"},{"key":"1706_CR11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/jnci\/djq009","volume":"102","author":"S Mocellin","year":"2010","unstructured":"Mocellin S, Pasquali S, Rossi CR, Nitti D. Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis. J Natl Cancer Inst. 2010;102:493\u2013501.","journal-title":"J Natl Cancer Inst."},{"issue":"Suppl. 6","key":"1706_CR12","doi-asserted-by":"crossref","first-page":"vi22","DOI":"10.1093\/annonc\/mdp257","volume":"20","author":"A Testori","year":"2009","unstructured":"Testori A, Rutkowski P, Marsden J, et al. Surgery and radiotherapy in the treatment of cutaneous melanoma. Ann Oncol. 2009;20(Suppl. 6):vi22\u20139.","journal-title":"Ann Oncol"},{"key":"1706_CR13","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/cncr.23306","volume":"112","author":"W Mendenhall","year":"2008","unstructured":"Mendenhall W, Amdur R, Grobmeyer S, et al. Adjuvent radiotherapy for cutaneous melanoma. Cancer. 2008;112:1189\u201396.","journal-title":"Cancer."},{"key":"1706_CR14","unstructured":"America.gov. Increasing diversity predicted in U.S. population: Hispanic and Asian populations both poised to triple. 2004. http:\/\/www.america.gov\/st\/washfile-english\/2004\/March\/20040318124311CMretroP0.4814264.html (July 15, 2010)."},{"key":"1706_CR15","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s10552-004-1324-5","volume":"15","author":"RM Merrill","year":"2004","unstructured":"Merrill RM, Dearden KA. How representative are the surveillance, epidemiology, and end results (SEER) program cancer data of the United States? Cancer Causes Control. 2004;15:1027\u201334.","journal-title":"Cancer Causes Control."},{"key":"1706_CR16","volume-title":"International Classification of Diseases for Oncology","author":"A Fritz","year":"2000","unstructured":"Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S. International classification of diseases for oncology, 3rd edn. Geneva, Switzerland: World Health Organization; 2000.","edition":"3"},{"key":"1706_CR17","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3656-4","volume-title":"American Joint Committee on Cancer staging manual","author":"FL Greene","year":"2002","unstructured":"Greene FL, Page DL, Fleming ID, et al. American Joint Committee on Cancer staging manual, 6th edn. New York: Springer; 2002.","edition":"6"},{"key":"1706_CR18","volume-title":"Manual for tumor nomenclature and coding","author":"American Cancer Society","year":"1968","unstructured":"American Cancer Society. Manual for tumor nomenclature and coding. New York: American Cancer Society; 1968."},{"key":"1706_CR19","unstructured":"Shambaugh E. SEER extent of disease: codes and coding instructions. National Cancer Institute; 1984."},{"key":"1706_CR20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/jnci\/94.5.334","volume":"94","author":"VL Shavers","year":"2002","unstructured":"Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94:334\u201357.","journal-title":"J Natl Cancer Inst."},{"key":"1706_CR21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jso.1116","volume":"78","author":"C Bellows","year":"2001","unstructured":"Bellows C, Bellafsy P, Fortang I, Beech D. Melanoma in African Americans: trends in biological behavior and clinical characteristics over two decades. J Surg Oncol. 2001;78:10\u20136.","journal-title":"J Surg Oncol."},{"key":"1706_CR22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1047-2797(97)00231-7","volume":"8","author":"RA Harrison","year":"1998","unstructured":"Harrison RA, Haque AU, Roseman JM, Soong SJ. Socioeconomic characteristics and melanoma incidence. Ann Epidemiol. 1998;8:327\u201333.","journal-title":"Ann Epidemiol."},{"key":"1706_CR23","first-page":"101","volume":"90","author":"A Polednak","year":"1998","unstructured":"Polednak A. Prostate cancer treatment in African American and Caucasian men: the need to consider both stage at diagnosis and socioeconomic status. J Natl Med Assoc. 1998;90:101\u20134.","journal-title":"J Natl Med Assoc."},{"key":"1706_CR24","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S1047-2797(00)00038-7","volume":"10","author":"G Howard","year":"2000","unstructured":"Howard G, Anderson RT, Russell G, Howard VJ, Burke GL. Race, socioeconomic status, and cause-specific mortality. Ann Epidemiol. 2000;10:214\u201323.","journal-title":"Ann Epidemiol."},{"key":"1706_CR25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3322\/canjclin.54.2.78","volume":"54","author":"E Ward","year":"2004","unstructured":"Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race\/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54:78\u201393.","journal-title":"CA Cancer J Clin."},{"key":"1706_CR26","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/sj.bjc.6602623","volume":"92","author":"R Neal","year":"2005","unstructured":"Neal R, Allgar V. Sociodemographic factors and delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS Patients: cancer. Br J Cancer. 2005;92:1971\u20135.","journal-title":"Br J Cancer."},{"key":"1706_CR27","doi-asserted-by":"crossref","first-page":"IV19","DOI":"10.1097\/00005650-200208001-00003","volume":"40","author":"P Bach","year":"2002","unstructured":"Bach P, Guadagnoli E, Schrag D, Schussler N, Warren J. Patient demographic and socioeconomic characteristics in the SEER-Medicare database: applications and limitations. Med Care. 2002;40:IV19\u201325.","journal-title":"Med Care."},{"key":"1706_CR28","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1200\/JCO.2004.06.020","volume":"22","author":"JZ Ayanian","year":"2004","unstructured":"Ayanian JZ, Chrischilles EA, Wallace RB, et al. Understanding cancer treatment and outcomes: the cancer care outcomes research and surveillance consortium. J Clin Oncol. 2004;22:2992\u20136.","journal-title":"J Clin Oncol."},{"key":"1706_CR29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2105\/AJPH.93.2.200","volume":"93","author":"DR Williams","year":"2003","unstructured":"Williams DR, Neighbors HW, Jackson JS. Racial\/ethnic discrimination and health: findings from community studies. Am J Public Health. 2003;93:200\u20138.","journal-title":"Am J Public Health."},{"key":"1706_CR30","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0090-4295(94)80196-7","volume":"44","author":"R Morton","year":"1994","unstructured":"Morton R. Racial differences in adenocarcinoma of the prostate in North American men. Urology. 1994;44:637\u201345.","journal-title":"Urology."},{"key":"1706_CR31","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1001\/jama.274.20.1599","volume":"274","author":"SA Optenberg","year":"1995","unstructured":"Optenberg SA, Thompson IM, Friedrichs P, Wojcik B, Stein CR, Kramer B. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA. 1995;274:1599\u2013605.","journal-title":"JAMA."},{"key":"1706_CR32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archinte.163.1.49","volume":"163","author":"CI Li","year":"2003","unstructured":"Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 2003;163:49\u201356.","journal-title":"Arch Intern Med."},{"key":"1706_CR33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1023\/A:1022255800411","volume":"22","author":"VL Shavers","year":"2003","unstructured":"Shavers VL, Harlan LC, Winn D, Davis WW. Racial\/ethnic patterns of care for cancers of the oral cavity, pharynx, larynx sinuses and salivary glands. Cancer Metastasis Rev. 2003;22:25\u201338.","journal-title":"Cancer Metastasis Rev."},{"key":"1706_CR34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/pros.20052","volume":"62","author":"S Freedland","year":"2005","unstructured":"Freedland S, Isaacs W. Explaining racial differences in prostate cancer in the United States: sociology or biology? Prostate. 2005;62:243\u20132.","journal-title":"Prostate."},{"key":"1706_CR35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.bjc.6600428","volume":"87","author":"U Hoffman","year":"2002","unstructured":"Hoffman U, Szedlak M, Rittgen W, Jung E, Schadendorf D. Primary staging and follow-up in melanoma patients-monocenter evaluation of methods, costs and patient survival. Br J Cancer. 2002;87:151\u20137.","journal-title":"Br J Cancer."},{"key":"1706_CR36","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1200\/JCO.2005.05.169","volume":"23","author":"E Streyerberg","year":"2005","unstructured":"Streyerberg E, Earle C, Nevile B, Weeks J. Racial differences in surgical evaluation, treatment and outcome of locoregional esophageal cancer: a population-based analysis of elderly patients. J Clin Oncol. 2005;23:510\u20137.","journal-title":"J Clin Oncol."},{"key":"1706_CR37","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archdermatol.2008.609","volume":"145","author":"PT Bradford","year":"2009","unstructured":"Bradford PT, Goldstein AM, McMaster ML, Tucker MA. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986\u20132005. Arch Dermatol. 2009;145:427\u201334.","journal-title":"Arch Dermatol."},{"key":"1706_CR38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0190-9622(03)02091-7","volume":"50","author":"KM Byrd","year":"2004","unstructured":"Byrd KM, Wilson DC, Hoyler SS, Peck GL. Advanced presentation of melanoma in African Americans. J Am Acad Dermatol. 2004;50:21\u20134.","journal-title":"J Am Acad Dermatol."},{"key":"1706_CR39","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.clindermatol.2008.09.014","volume":"27","author":"D Albreski","year":"2009","unstructured":"Albreski D, Sloan S. Melanoma of the feet: misdiagnosed and misunderstood. Clin Dermatol. 2009;27:556\u201363.","journal-title":"Clin Dermatol."},{"key":"1706_CR40","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jaad.2004.05.005","volume":"51","author":"S Hu","year":"2004","unstructured":"Hu S, Parker D, Thomas A, Kirsner R. Advanced presentation of melanoma in African Americans: the Miami-Dade County experience. J Am Acad Dermatol. 2004;51:1031\u20132.","journal-title":"J Am Acad Dermatol."},{"key":"1706_CR41","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1023\/A:1018432632528","volume":"8","author":"R Cress","year":"1997","unstructured":"Cress R, Holly E. Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians and blacks: an analysis of California Cancer Registry data, 1988\u201393. Cancer Causes Control. 1997;8:246\u201352.","journal-title":"Cancer Causes Control."},{"key":"1706_CR42","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/archderm.142.6.704","volume":"142","author":"S Hu","year":"2006","unstructured":"Hu S, Soza-Vento RM, Parker DF, Kirsner RS. Comparison of stage at diagnosis of melanoma among hispanic, black, and white patients in Miami-Dade County, Florida. Arch Dermatol. 2006;142:704\u20138.","journal-title":"Arch Dermatol."},{"key":"1706_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1524-4725.2007.33000.x","volume":"33","author":"A Hutchenson","year":"2007","unstructured":"Hutchenson A, McGowen J, Maize J, Cook J. Multiple primary and acral melanomas in African Americans: a case series and review of the literature. Dermatol Surg. 2007;33:1\u201310.","journal-title":"Dermatol Surg."},{"key":"1706_CR44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0039-6109(02)00093-2","volume":"83","author":"DS Johnson","year":"2003","unstructured":"Johnson DS, Yamane S, Morita S, Yonehara C, Wong JH. Malignant melanoma in non-caucasians: experience from Hawaii. Surg Clin N Am. 2003;83:275\u201382.","journal-title":"Surg Clin N Am."},{"key":"1706_CR45","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/CCO.0b013e32801497d7","volume":"19","author":"G Parmiani","year":"2007","unstructured":"Parmiani G, Castelli C, Santinami M, Rivoltini L. Melanoma immunology: past, present and future. Curr Opin Oncol. 2007;19:121\u20137.","journal-title":"Curr Opin Oncol."},{"key":"1706_CR46","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/cncr.21251","volume":"104","author":"J Guidry","year":"2005","unstructured":"Guidry J, Torrence W, Herbelin S. Closing the divide: diverse populations and cancer survivorship. Cancer. 2005;104:2577\u201383.","journal-title":"Cancer."},{"key":"1706_CR47","unstructured":"SEER. Population characteristics. 2010. http:\/\/seer.cancer.gov\/registries\/characteristics.html (December 17, 2010)."},{"key":"1706_CR48","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF03256334","volume":"13","author":"N Haass","year":"2009","unstructured":"Haass N, Smalley K. Melanoma biomarkers: current status and utility in diagnosis, prognosis and response to therapy. Mol Diag Ther. 2009;13:283\u201396.","journal-title":"Mol Diag Ther."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-011-1706-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-011-1706-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-011-1706-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T03:19:17Z","timestamp":1592450357000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-011-1706-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,9]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["1706"],"URL":"https:\/\/doi.org\/10.1245\/s10434-011-1706-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,9]]}}}